Katharina Schieber1, Ines Kollei2, Martina de Zwaan3, Alexandra Martin4. 1. Department of Psychosomatic Medicine and Psychotherapy, University Hospital of Erlangen, University of Erlangen-Nuernberg, Schwabachanlage 6, 91054 Erlangen, Germany. Electronic address: katharina.schieber@uk-erlangen.de. 2. (b)Department of Clinical Psychology and Psychotherapy, University of Erlangen-Nuernberg, Nägelsbachstr. 25a, 91052 Erlangen, Germany. 3. (c)Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. 4. (d)Department of Clinical Psychology and Psychotherapy, University of Wuppertal, Max-Horkheimer-Str. 20, 42097 Wuppertal, Germany.
Abstract
OBJECTIVE: In DSM-5 the diagnosis of body dysmorphic disorder (BDD) has been subjected to two important changes: Firstly, BDD has been assigned to the category of obsessive-compulsive and related disorders. Secondly, a new criterion has been defined requiring the presence of repetitive behaviors or mental acts in response to appearance concerns. The aims of this study were to report the prevalence rates of BDD based on a DSM-5 diagnosis, and to evaluate the impact of the recently introduced DSM-5 criteria for BDD by comparing the prevalence rates (DSM-5 vs. DSM-IV) METHODS: BDD-criteria (DSM-IV/DSM-5), dysmorphic concerns, and depressive symptoms, were assessed in a representative sample of the German general population (N=2129, aged 18-65years). RESULTS: The association between BDD case identification based on DSM-IV and DSM-5 was strong (Phi=.95, p<.001), although point prevalence of BDD according to DSM-5 was slightly lower (2.9%, n=62 vs. 3.2%, n=68). Approximately one third of the identified BDD (DSM-5) cases reported time-consuming behavioral acts in response to appearance concerns. In detail, 0.8% of the German general population fulfilled the BDD criteria and reported repetitive acts of at least one hour/day. CONCLUSIONS: The revised criteria of BDD in DSM-5 do not seem to have an impact on prevalence rates. However, the recently added B-criterion reflects more precisely the clinical symptoms of BDD, and may be useful for distinguishing between various severity levels related to repetitive behaviors/mental acts.
OBJECTIVE: In DSM-5 the diagnosis of body dysmorphic disorder (BDD) has been subjected to two important changes: Firstly, BDD has been assigned to the category of obsessive-compulsive and related disorders. Secondly, a new criterion has been defined requiring the presence of repetitive behaviors or mental acts in response to appearance concerns. The aims of this study were to report the prevalence rates of BDD based on a DSM-5 diagnosis, and to evaluate the impact of the recently introduced DSM-5 criteria for BDD by comparing the prevalence rates (DSM-5 vs. DSM-IV) METHODS: BDD-criteria (DSM-IV/DSM-5), dysmorphic concerns, and depressive symptoms, were assessed in a representative sample of the German general population (N=2129, aged 18-65years). RESULTS: The association between BDD case identification based on DSM-IV and DSM-5 was strong (Phi=.95, p<.001), although point prevalence of BDD according to DSM-5 was slightly lower (2.9%, n=62 vs. 3.2%, n=68). Approximately one third of the identified BDD (DSM-5) cases reported time-consuming behavioral acts in response to appearance concerns. In detail, 0.8% of the German general population fulfilled the BDD criteria and reported repetitive acts of at least one hour/day. CONCLUSIONS: The revised criteria of BDD in DSM-5 do not seem to have an impact on prevalence rates. However, the recently added B-criterion reflects more precisely the clinical symptoms of BDD, and may be useful for distinguishing between various severity levels related to repetitive behaviors/mental acts.
Authors: Sabine Wilhelm; Katharine A Phillips; Jennifer L Greenberg; Sheila M O'Keefe; Susanne S Hoeppner; Aparna Keshaviah; Suraj Sarvode-Mothi; David A Schoenfeld Journal: JAMA Psychiatry Date: 2019-04-01 Impact factor: 21.596
Authors: Jennifer L Greenberg; Nicholas C Jacobson; Susanne S Hoeppner; Emily E Bernstein; Ivar Snorrason; Anna Schwartzberg; Gail Steketee; Katharine A Phillips; Sabine Wilhelm Journal: J Psychiatr Res Date: 2022-06-08 Impact factor: 5.250
Authors: Hilary Weingarden; Susanne S Hoeppner; Ivar Snorrason; Jennifer L Greenberg; Katharine A Phillips; Sabine Wilhelm Journal: Depress Anxiety Date: 2021-03-16 Impact factor: 8.128
Authors: Georgina Krebs; Lorena Fernández de la Cruz; Frühling V Rijsdijk; Daniel Rautio; Jesper Enander; Christian Rück; Paul Lichtenstein; Sebastian Lundström; Henrik Larsson; Thalia C Eley; David Mataix-Cols Journal: Psychol Med Date: 2020-09-17 Impact factor: 10.592